Leading Online Pharmacy
100% Genuine Products
  Wide Collection of Prescription
& OTC Products
  We Accept eCheck
Secure and Faster payment gateway

Minirin 0.1mg

Out Of Stock

This product is temporarily unavailable due to supply issues. Please leave your e-mail address so we can update you as soon as the product is in stock:
More Information
SKU: 3002
Generic For: Ddavp
Active Ingredient: Desmopressin
Manufacturer: Ferring Pharmaceuticals, Switzerland
Customer Reviews
Write Your Own Review

Minirin 0.1 mg contains Desmopressin 0.1 mg, a synthetic analogue of the naturally occurring hormone vasopressin. It is an antidiuretic medicine that helps the kidneys retain water and reduce excessive urine production. It is used when reducing urine production or replacing antidiuretic hormone activity is clinically appropriate. Desmopressin tablets may be used for central cranial diabetes insipidus, where the body does not produce enough effective vasopressin, and for primary nocturnal enuresis, commonly known as bedwetting. For central diabetes insipidus, insufficient antidiuretic hormone activity can cause the kidneys to produce unusually large amounts of dilute urine, often accompanied by excessive thirst.

Desmopressin helps compensate for this deficiency by providing an antidiuretic effect. When used for primary nocturnal enuresis, Desmopressin can reduce nighttime urine production and help decrease episodes of bedwetting in appropriately selected patients. Treatment recommendations vary by age and formulation, so do not change the prescribed strength without consulting your doctor.

How Desmopressin 0.1 mg works

Desmopressin, the active ingredient in Minirin, mimics vasopressin, also known as antidiuretic hormone (ADH). Vasopressin normally signals the kidneys to conserve water rather than eliminate it rapidly as urine. After Desmopressin produces its antidiuretic effect, the kidneys retain more water and produce a smaller volume of urine. This makes the urine more concentrated and helps reduce excessive water loss. This mechanism explains why Minirin 0.1 mg for bedwetting can help selected patients whose nighttime urine production contributes to wetting episodes. It also explains its role in managing central diabetes insipidus, where the body lacks adequate natural antidiuretic hormone activity. Desmopressin increases water retention; fluid intake is an important part of safe treatment. Taking the medicine while drinking excessive amounts of fluid can increase the risk of water retention and hyponatraemia (low blood sodium).

Buy authentic Minirin 0.1 mg online

Online purchasing from a trustworthy platform allows you to review important product information, including the active ingredient, strength, usage instructions, precautions, and possible side effects, before placing an order. Ordering Minirin 0.1 mg online from a reliable store like AllDayChemist (ADC) can make it easier to access your prescribed medicine without visiting a pharmacy in person. If you're looking for other options related to Minirin 0.1 mg, ADC may offer different desmopressin formulations or strengths, depending on availability. You can explore the Minirin 0.1 mg product page and browse other available medicines at AllDayChemist to find related products and strengths. Consult a doctor when you switch strength, alternate medicines, or change the treatment duration.

 

Precautions before using Desmopressin

 

Before starting Minirin 0.1 mg, tell the doctor if you have kidney disease, cardiovascular disease, low blood sodium, fluid or electrolyte imbalance, or conditions associated with excessive fluid intake. Desmopressin requires particular caution in people with impaired kidney function because its antidiuretic effect may be altered. Minirin should not be used in certain patients with hyponatraemia, moderate or severe renal impairment, cardiac insufficiency, or conditions requiring treatment with diuretics, depending on the indication and formulation. For children receiving Desmopressin for bedwetting, appropriate assessment is important before treatment. Conditions such as significant bladder dysfunction or urinary outflow obstruction may require evaluation before Desmopressin is considered. Treatment may also need to be interrupted during illnesses associated with fluid or electrolyte disturbances, such as vomiting, diarrhoea, fever, or significant systemic illness.

 

Medicines that can interact with Minirin: Tell the doctor about all medicines you take before starting Desmopressin 0.1 mg. Some medicines can enhance Desmopressin's antidiuretic effects and consequently increase the risk of water retention or hyponatraemia. Medicines that require particular attention include certain antidepressants such as selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants, carbamazepine, chlorpromazine, some antidiabetic medicines, and NSAIDs. Loperamide may also increase Desmopressin exposure. This does not mean that every patient taking one of these medicines cannot use Minirin. Instead, the combination may require an appropriate assessment of the risks, fluid intake, dosage, and monitoring requirements. Always mention over-the-counter pain medicines such as ibuprofen, as well as prescription medicines, vitamins, and herbal supplements, when your medication history is reviewed.

 

Minirin during pregnancy and breastfeeding: If you are pregnant, planning pregnancy, or breastfeeding, discuss Minirin treatment before starting or changing the dose. The decision to use Desmopressin during pregnancy depends on the indication and individual circumstances. Available prescribing information advises caution when using Desmopressin during pregnancy, with appropriate monitoring where indicated. Available lactation data suggest that only very small amounts of Desmopressin reach breast milk and are not expected to produce a meaningful antidiuretic effect in the nursing infant. Do not discontinue prescribed Desmopressin abruptly or substitute another medicine without discussing the change with the professional managing your treatment.

 

Desmopressin’s side effects

 

Possible Minirin 0.1 mg side effects include headache, nausea, abdominal discomfort, vomiting, dizziness, and other gastrointestinal or neurological symptoms. The most clinically important adverse effect of desmopressin is hyponatraemia caused by excessive water retention. Some patients may experience fatigue, peripheral oedema, or other symptoms. Side effects can vary depending on the dose, formulation, age, medical condition, kidney function, fluid intake, and medicines used at the same time.

 

Warning signs of low sodium: Contact your doctor straight away if you develop a persistent or severe headache, nausea or vomiting, unusual weight gain, marked tiredness, muscle cramps, confusion, or unusual drowsiness while taking Desmopressin. Seizures, severe confusion, reduced consciousness, or other serious neurological symptoms require urgent medical attention, as they can occur with severe hyponatraemia. Do not try to treat suspected hyponatraemia by changing the Minirin dose yourself. Medical assessment is important because the appropriate response depends on the severity and cause of the sodium disturbance.

Taking Desmopressin correctly

 

The correct Minirin 0.1 mg dosage depends on the condition being treated and the individual's response to treatment. Desmopressin dosing for primary nocturnal enuresis differs from dosing used for diabetes insipidus, and different Desmopressin formulations are not necessarily dose equivalent. Take the tablet exactly as prescribed. Swallow the oral tablet as directed and do not change the dose because symptoms improve or worsen. If you are using Minirin for bedwetting, pay close attention to fluid restriction. Current Desmopressin prescribing information advises limiting fluid intake from approximately one hour before administration until the following morning, or for at least eight hours after the dose, depending on the formulation and prescribing instructions. If you forget a dose, follow the missed-dose instructions supplied with your prescription. Do not take two doses together to compensate for a missed tablet.

 

Fluid restriction is an important part of treatment: One of the most important safety considerations with Minirin 0.1 mg is controlling fluid intake during treatment. Desmopressin tells the kidneys to retain water, so drinking excessive amounts can cause water accumulation and reduced blood sodium levels. Hyponatraemia can initially produce symptoms such as headache, nausea, vomiting, unusual tiredness, weight gain, or abdominal discomfort. More serious sodium disturbances can cause confusion, decreased consciousness, muscle cramps, seizures, and other neurological complications. Do not deliberately drink large amounts of water while taking Desmopressin unless specifically instructed to do so. Fluid recommendations may vary by medical condition, age, and formulation, so follow the instructions provided with your prescription.

 

Copyright © 2026 AllDayChemist. All rights reserved.